PRESS RELEASE published on 07/10/2023 at 07:00, 2 years 9 months ago Biophytis a demandé à la FDA l’autorisation de lancer l’étude SARA-31 de phase 3 dans la sarcopénie
PRESS RELEASE published on 06/19/2023 at 07:00, 2 years 10 months ago Biophytis présente les résultats cliniques de Sarconeos (BIO101) dans la sarcopénie au 16ème congrès international SCWD
PRESS RELEASE published on 06/19/2023 at 07:00, 2 years 10 months ago Biophytis reports clinical results for Sarconeos (BIO101) in sarcopenia treatment at the 16th SCWD International Congress
PRESS RELEASE published on 06/16/2023 at 23:00, 2 years 10 months ago Biophytis: RESULTS OF THE ANNUAL GENERAL MEETING ON JUNE 16, 2023 ALL RESOLUTIONS PRESENTED BY THE COMPANY HAVE BEEN ADOPTED
PRESS RELEASE published on 06/16/2023 at 23:00, 2 years 10 months ago RÉSULTATS DE L’ASSEMBLÉE GÉNÉRALE DU 16 JUIN 2023 ADOPTION DE L’ENSEMBLE DES RÉSOLUTIONS PRÉSENTÉES PAR LA SOCIÉTÉ
PRESS RELEASE published on 06/05/2023 at 08:00, 2 years 11 months ago Biophytis annonce sa participation à la BIO International Convention de Boston du 5 au 8 juin
PRESS RELEASE published on 06/05/2023 at 08:00, 2 years 11 months ago Biophytis to participate at the BIO International Convention in Boston from the 5th to the 8th of June
PRESS RELEASE published on 05/26/2023 at 08:00, 2 years 11 months ago Biophytis has filed with the French National Authority for Health (HAS) an application for Early Access Authorisation (EAA) for Sarconeos (BIO101) in the treatment of severe forms of COVID-1
PRESS RELEASE published on 05/26/2023 at 08:00, 2 years 11 months ago Biophytis a soumis à la Haute Autorité de Santé (HAS) une demande d’Autorisation d’Accès Précoce (AAP) pour Sarconeos (BIO101) dans le traitement des formes sévères de COVID-19
PRESS RELEASE published on 05/25/2023 at 08:00, 2 years 11 months ago Biophytis a présenté les résultats positifs de Phase 2-3 COVA à la Conférence internationale de l’American Thoracic Society
Published on 05/09/2026 at 01:30, 4 hours 6 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 5 hours 36 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 8 hours 58 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 10 hours 23 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 10 hours 34 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 10 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 10 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 10 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 10 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 10 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
